These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28135804)

  • 41. Equipoise as a means of managing uncertainty: personal, communal and proxy.
    Alderson P
    J Med Ethics; 1996 Jun; 22(3):135-9. PubMed ID: 8798934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and research ethics as moral strangers.
    Kottow MH
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):157-64. PubMed ID: 19479200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lay public's understanding of equipoise and randomisation in randomised controlled trials.
    Robinson EJ; Kerr CE; Stevens AJ; Lilford RJ; Braunholtz DA; Edwards SJ; Beck SR; Rowley MG
    Health Technol Assess; 2005 Mar; 9(8):1-192, iii-iv. PubMed ID: 15763039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Destabilizing the 'equipoise' framework in clinical trials: prioritizing non-exploitation as an ethical framework in clinical research.
    Schlichting DE
    Nurs Philos; 2010 Oct; 11(4):271-9. PubMed ID: 20840138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Gini coefficient as a measure for understanding accrual inequalities in multicenter clinical studies.
    Haidich AB; Ioannidis JP
    J Clin Epidemiol; 2004 Apr; 57(4):341-8. PubMed ID: 15135834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The intellectual challenges and emotional consequences of equipoise contributed to the fragility of recruitment in six randomized controlled trials.
    Donovan JL; de Salis I; Toerien M; Paramasivan S; Hamdy FC; Blazeby JM
    J Clin Epidemiol; 2014 Aug; 67(8):912-20. PubMed ID: 24811157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical trials and the COVID-19 pandemic.
    Retsas S
    Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measuring clinical uncertainty and equipoise by applying the agreement study methodology to patient management decisions.
    Fahed R; Darsaut TE; Farzin B; Chagnon M; Raymond J
    BMC Med Res Methodol; 2020 Aug; 20(1):214. PubMed ID: 32842953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual Uncertainties: On Equipoise, Sex Differences and Chirality in Clinical Research.
    Dahlen S
    New Bioeth; 2021 Sep; 27(3):219-229. PubMed ID: 33944708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Equipoise in clinical nursing research.
    McCleary L
    Can J Nurs Res; 2002 Oct; 34(3):49-60. PubMed ID: 12425010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Equipoise across the patient population: optimising recruitment to a randomised controlled trial.
    Whybrow P; Pickard R; Hrisos S; Rapley T
    Trials; 2017 Mar; 18(1):140. PubMed ID: 28347354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A case of insufficient evidence equipoise: the NICE guidance on antibiotic prophylaxis for the prevention of infective endocarditis.
    Mohindra RK
    J Med Ethics; 2010 Sep; 36(9):567-70. PubMed ID: 20663759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Balancing high accrual and ethical recruitment in paediatric oncology: a qualitative study of the 'look and feel' of clinical trial discussions.
    Byrne-Davis LM; Salmon P; Gravenhorst K; Eden TO; Young B
    BMC Med Res Methodol; 2010 Oct; 10():101. PubMed ID: 20969763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ethics of Adaptive Designs for Randomized Controlled Trials.
    Chongwe G; Ali J; Kaye DK; Michelo C; Kass NE
    Ethics Hum Res; 2023; 45(5):2-14. PubMed ID: 37777976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patient-centred equipoise and the ethics of randomised controlled trials.
    Olson LG
    Monash Bioeth Rev; 2002 Apr; 21(2):S55-67. PubMed ID: 15828162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gatekeeping in cancer clinical trials in Canada: The ethics of recruiting the "ideal" patient.
    Bell JAH; Kelly MT; Gelmon K; Chi K; Ho A; Rodney P; Balneaves LG
    Cancer Med; 2020 Jun; 9(12):4107-4113. PubMed ID: 32314549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The irrelevance of equipoise.
    Veatch RM
    J Med Philos; 2007; 32(2):167-83. PubMed ID: 17454421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S69-80. PubMed ID: 17413266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.
    Crow RA; Hart KA; McDermott MP; Tawil R; Martens WB; Herr BE; McColl E; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Hirtz D; Lochmuller H; Straub V; Ciafaloni E; Shieh PB; Spinty S; Childs AM; Manzur AY; Morandi L; Butterfield RJ; Horrocks I; Roper H; Flanigan KM; Kuntz NL; Mah JK; Morrison L; Darras BT; von der Hagen M; Schara U; Wilichowski E; Mongini T; McDonald CM; Vita G; Barohn RJ; Finkel RS; Wicklund M; McMillan HJ; Hughes I; Pegoraro E; Bryan Burnette W; Howard JF; Thangarajh M; Campbell C; Griggs RC; Bushby K; Guglieri M
    Trials; 2018 May; 19(1):291. PubMed ID: 29793540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized controlled trials of maternal-fetal surgery: a challenge to clinical equipoise.
    Rodrigues HC; van den Berg PP
    Bioethics; 2014 Oct; 28(8):405-13. PubMed ID: 23025329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.